EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Safety and Feasibility of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy With Calcium‐Containing Solutions: A Randomized Controlled Trial

Shan Huang, Guangfeng Sun, Penglong Wu, LinJing Wu, Hongfei Jiang, Xixing Wang, Liyuan Li, Lingling Gao, Fanqi Meng iD

Seminars in Dialysis · 2024

DOI: 10.1111/sdi.13200 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Seminars in Dialysis, 2024. Verfasst von Shan Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China. Hauptthemen laut MEDLINE: Continuous Renal Replacement Therapy, Anticoagulants, Feasibility Studies, Citric Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xiamen Science and Technology Project, Science and Technology Projects of Fujian Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Calcium‐free (Ca‐free) solutions are theoretically the most ideal for regional citrate anticoagulation (RCA) in continuous renal replacement therapy (CRRT). However, the majority of medical centers in China had to make a compromise of using commercially available calcium‐containing (Ca‐containing) solutions instead of Ca‐free ones due to their scarcity. This study was designed to probe into the potential of Ca‐containing solution as a secure and efficient substitution for Ca‐free solutions.

Methods

In this prospective, randomized single‐center trial, 99 patients scheduled for CRRT were randomly assigned in a 1:1:1 ratio to one of three treatment groups: continuous veno‐venous hemodialysis Ca‐free dialysate (CVVHD Ca‐free) group, continuous veno‐venous hemodiafiltration calcium‐free dialysate (CVVHDF Ca‐free) group, and continuous veno‐venous hemodiafiltration Ca‐containing dialysate (CVVHDF Ca‐containing) group at cardiac intensive care unit (CICU). The primary endpoint was the incidence of metabolic complications. The secondary endpoints included premature termination of treatment, thrombus of filter, and bubble trap after the process.

Results

The incidence of citrate accumulation (18.2% vs. 12.1% vs. 21.2%) and metabolic alkalosis (12.1% vs. 0% vs. 9.1%) did not significantly differ among three groups ( p > 0.05 for both). The incidence of premature termination was comparable among the groups (18.2% vs. 9.1% vs. 9.1%, p = 0.582). The thrombus level of the filter and bubble trap was similar in the three groups ( p > 0.05 for all).

Conclusions

In RCA‐CRRT for CICU population, RCA‐CVVHDF with Ca‐containing solutions and traditional RCA with Ca‐free solutions had a comparable safety and feasibility. Trial Registration: ChiCTR2100048238 in the Chinese Clinical Trial Registry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Continuous Renal Replacement TherapyAnticoagulantsFeasibility StudiesCitric AcidDialysis SolutionsHumansFemaleMaleMiddle AgedProspective StudiesAgedChinaCalciumAcute Kidney Injury

Stichwörter der Autor:innen

calcium‐containing solutionscontinuous renal replacement therapymetabolic complicationsregional citrate anticoagulationthrombus

Substanzen

AnticoagulantsCitric AcidDialysis SolutionsCalcium

Autor:innen und Institutionen

  • Department of Cardiology, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
  • Department of Emergency, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.

ORCID-Profile: Fanqi Meng

Förderung

  • Xiamen Science and Technology Project
  • Science and Technology Projects of Fujian Province
  • National Natural Science Foundation of China

Zitieren

APA

Huang, S., Sun, G., Wu, P., Wu, L., Jiang, H., Wang, X., Li, L., Gao, L., & Meng, F. (2024). Safety and Feasibility of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy With Calcium‐Containing Solutions: A Randomized Controlled Trial. Seminars in Dialysis. https://doi.org/10.1111/sdi.13200

Vancouver

Huang S, Sun G, Wu P, Wu L, Jiang H, Wang X, et al. Safety and Feasibility of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy With Calcium‐Containing Solutions: A Randomized Controlled Trial. Seminars in Dialysis. 2024. doi:10.1111/sdi.13200

BibTeX
@article{Huang2024,
  author = {Huang, Shan and Sun, Guangfeng and Wu, Penglong and Wu, LinJing and Jiang, Hongfei and Wang, Xixing and Li, Liyuan and Gao, Lingling and Meng, Fanqi},
  title = {Safety and Feasibility of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy With Calcium‐Containing Solutions: A Randomized Controlled Trial},
  journal = {Seminars in Dialysis},
  year = {2024},
  doi = {10.1111/sdi.13200}
}
Kostenlos starten →